EyePoint Pharmaceuticals, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • EyePoint Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -43 %, a 68.8% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Return On Equity for 2023 was -61.5 %, a 17.2% increase from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Return On Equity for 2022 was -74.2 %, a 58.8% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Return On Equity for 2021 was -46.8 %, a 87.9% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.